Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients.: Preliminary results of a phase I/II trial.

被引：0
|
作者：
Losa, F
Manzano, H
Vicente, P
Rifa, J
Ocaña, J
Balcells, M
Mediavilla, D
Heras, L
机构：
[1] Hosp creu Roja, Lhospitalet De Llobregat, Spain
[2] Hosp Son Dureta, Palma de Mallorca, Spain
[3] Hosp Gen Granollers, Granollers, Spain
[4] Almirall Prodesfarma SA, Barcelona, Spain
[5] Rec Clin SL, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3675
引用
收藏
页码：288S / 288S
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of irinotecan (CPT-11) combined with 1-leucovorin (I-LV) and 5FU in patients with advanced colorectal cancer
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 437 - 437
  • [42] Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy
    García-Girón C.
    Palomo A.G.
    López C.A.
    Carbonero A.L.
    Ureña M.M.
    Cebrián E.A.
    Galíndez R.B.
    Yustos M.A.
    Gallego J.A.
    Clinical and Translational Oncology, 2005, 7 (6) : 244 - 249
  • [43] Irinotecan (CPT-11) in 5-FU pretreated advanced colorectal cancer: Results in 174 expanded access patients
    Iveson, T
    Eggleton, SPH
    Hickish, T
    Cunningham, D
    Maughan, T
    Harper, P
    ANNALS OF ONCOLOGY, 1998, 9 : 36 - 37
  • [44] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Koji Okabayashi
    Hirotoshi Hasegawa
    Yoshiyuki Ishii
    Takashi Endo
    Hiroki Ochiai
    Tetsuro Kubota
    Yuko Kitagawa
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 501 - 507
  • [45] Phase II study of irinotecan (CPT 11) in patients whit not pretreated advanced colorectal cancer.
    Salgado, M
    Menéndez, D
    Sabin, P
    Diz, P
    Constenia-Figueiras, M
    Casai, J
    Calvo, L
    Castellanos, J
    Balcells, M
    Firvida, JL
    Irigoyen, A
    Quintero, G
    Garcia-Palomo, A
    García-Arroyo, FR
    Huidobro, G
    Valladares, M
    Garcia-Mata, J
    Vázquez, S
    De las Peñas, R
    Lorenzo, I
    Xaries, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S74 - S74
  • [46] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Okabayashi, Koji
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Endo, Takashi
    Ochiai, Hiroki
    Kubota, Tetsuro
    Kitagawa, Yuko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 501 - 507
  • [47] A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma
    Enzinger, PC
    Kulke, MH
    Clark, JW
    Ryan, DP
    Kim, H
    Earle, CC
    Vincitore, MM
    Michelini, AL
    Mayer, RJ
    Fuchs, CS
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) : 2218 - 2223
  • [48] A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma
    Peter C. Enzinger
    Matthew H. Kulke
    Jeffrey W. Clark
    David P. Ryan
    Haesook Kim
    Craig C. Earle
    Michele M. Vincitore
    Ann L. Michelini
    Robert J. Mayer
    Charles S. Fuchs
    Digestive Diseases and Sciences, 2005, 50 : 2218 - 2223
  • [49] Final results of a multicenter phase II study of irinotecan (CPT-11) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Boige, V
    Taieb, J
    Hebbar, M
    Magherini, E
    Mignard, D
    Debaere, T
    Hannoun, L
    Tigaud, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 358S - 358S
  • [50] Phase I dose finding trial of irinotecan (CPT-11) combined with ifosfamide (IFO) in patients with advanced solid tumors
    Garcia-Lopez, JL
    Segui, MA
    Abad, T
    Gimenez-Arnau, JM
    Moyano, A
    Nogue, M
    Dominguez, S
    Xarles, J
    ANNALS OF ONCOLOGY, 1998, 9 : 136 - 136
12345